Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridizationAD Murdoch, B Liu, R Schwarting, RS Tuan and RV Iozzo Department of Pathology and Cell Biology, Thomas Jefferson University, Philadelphia 19107. Perlecan, a multidomain heparan sulfate proteoglycan (PG), is an intrinsic component of basement membranes and extracellular matrices. We used a prokaryotic expression vector to generate fusion proteins encoding various domains of human perlecan protein core and these recombinant proteins were used as immunogens to produce mouse anti- human monoclonal antibodies (MAb). One MAb, designated 7B5, was characterized by Western blotting and ELISA and was shown to react specifically with the laminin-like region of perlecan (Domain III) but not with two other fusion proteins encoding Domain II or V. This perlecan epitope was detected by immunoenzymatic staining in the basement membranes of human tissues including pituitary gland, skin, breast, thymus, prostate, colon, liver, pancreas, spleen, heart, and lung. All vascular basement membranes tested contained this gene product. In addition, sinusoidal vessels of liver, spleen, lymph nodes, and pituitary gland expressed high levels of perlecan in the subendothelial region. In situ hybridization, using as probe the same human cDNA-encoding Domain III, localized perlecan mRNA to specific cell types within the tissues and demonstrated that in skin, perlecan appears to be synthesized exclusively by connective tissue cells in the dermal layer. The availability of MAb against precise regions of human perlecan will allow the investigation of this gene product in normal and diseased states.
Volume 42,
Issue 2,
pp. 239-249,
02/01/1994
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
C. Zuber, G. Mitteregger, N. Schuhmann, C. Rey, S. Knackmuss, W. Rupprecht, U. Reusch, C. Pace, M. Little, H. A. Kretzschmar, et al. Delivery of single-chain antibodies (scFvs) directed against the 37/67 kDa laminin receptor into mice via recombinant adeno-associated viral vectors for prion disease gene therapy J. Gen. Virol., August 1, 2008; 89(8): 2055 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Melrose, P. Roughley, S. Knox, S. Smith, M. Lord, and J. Whitelock The Structure, Location, and Function of Perlecan, a Prominent Pericellular Proteoglycan of Fetal, Postnatal, and Mature Hyaline Cartilages J. Biol. Chem., December 1, 2006; 281(48): 36905 - 36914. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bix, R. Castello, M. Burrows, J. J. Zoeller, M. Weech, R. A. Iozzo, C. Cardi, M. L. Thakur, C. A. Barker, K. Camphausen, et al. Endorepellin In Vivo: Targeting the Tumor Vasculature and Retarding Cancer Growth and Metabolism. J Natl Cancer Inst, November 15, 2006; 98(22): 1634 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Quondamatteo, W. Krick, Y. Hagos, M.-H. Kruger, K. Neubauer-Saile, R. Herken, G. Ramadori, G. Burckhardt, and B. C. Burckhardt Localization of the sulfate/anion exchanger in the rat liver Am J Physiol Gastrointest Liver Physiol, May 1, 2006; 290(5): G1075 - G1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sher, S. Zisman-Rozen, L. Eliahu, J. M. Whitelock, N. Maas-Szabowski, Y. Yamada, D. Breitkreutz, N. E. Fusenig, E. Arikawa-Hirasawa, R. V. Iozzo, et al. Targeting Perlecan in Human Keratinocytes Reveals Novel Roles for Perlecan in Epidermal Formation J. Biol. Chem., February 24, 2006; 281(8): 5178 - 5187. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.A. DeCarlo and J.M. Whitelock The Role of Heparan Sulfate and Perlecan in Bone-regenerative Procedures Journal of Dental Research, February 1, 2006; 85(2): 122 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Girardin, S. HajMohammadi, B. Birmele, A. Helisch, N. W. Shworak, and A. I. de Agostini Synthesis of Anticoagulantly Active Heparan Sulfate Proteoglycans by Glomerular Epithelial Cells Involves Multiple 3-O-Sulfotransferase Isoforms and a Limiting Precursor Pool J. Biol. Chem., November 11, 2005; 280(45): 38059 - 38070. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tiedemann, T. Sasaki, E. Gustafsson, W. Gohring, B. Batge, H. Notbohm, R. Timpl, T. Wedel, U. Schlotzer-Schrehardt, and D. P. Reinhardt Microfibrils at Basement Membrane Zones Interact with Perlecan via Fibrillin-1 J. Biol. Chem., March 25, 2005; 280(12): 11404 - 11412. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Gonzalez, C. C. Reed, G. Bix, J. Fu, Y. Zhang, B. Gopalakrishnan, D. S. Greenspan, and R. V. Iozzo BMP-1/Tolloid-like Metalloproteases Process Endorepellin, the Angiostatic C-terminal Fragment of Perlecan J. Biol. Chem., February 25, 2005; 280(8): 7080 - 7087. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Melrose, S. Smith, and J. Whitelock Perlecan Immunolocalizes to Perichondrial Vessels and Canals in Human Fetal Cartilaginous Primordia in Early Vascular and Matrix Remodeling Events Associated with Diarthrodial Joint Development J. Histochem. Cytochem., November 1, 2004; 52(11): 1405 - 1413. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Menne, J.-K. Park, M. Boehne, M. Elger, C. Lindschau, T. Kirsch, M. Meier, F. Gueler, A. Fiebeler, F. H. Bahlmann, et al. Diminished Loss of Proteoglycans and Lack of Albuminuria in Protein Kinase C-{alpha}--Deficient Diabetic Mice Diabetes, August 1, 2004; 53(8): 2101 - 2109. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Vogl-Willis and I. J. Edwards High Glucose-Induced Alterations in Subendothelial Matrix Perlecan Leads to Increased Monocyte Binding Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 858 - 863. [Abstract] [Full Text] |
||||
![]() |
P.-T. Brinkkoetter, S. Holtgrefe, F. J. van der Woude, and B. A. Yard Angiotensin II Type 1-Receptor Mediated Changes in Heparan Sulfate Proteoglycans in Human SV40 Transformed Podocytes J. Am. Soc. Nephrol., January 1, 2004; 15(1): 33 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Jiang and J. R. Couchman Perlecan and Tumor Angiogenesis J. Histochem. Cytochem., November 1, 2003; 51(11): 1393 - 1410. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Gonzalez, M. Mongiat, S. J. Slater, R. Baffa, and R. V. Iozzo A Novel Interaction between Perlecan Protein Core and Progranulin: POTENTIAL EFFECTS ON TUMOR GROWTH J. Biol. Chem., October 3, 2003; 278(40): 38113 - 38116. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Melrose, S. Smith, P. Ghosh, and J. Whitelock Perlecan, the Multidomain Heparan Sulfate Proteoglycan of Basement Membranes, Is also a Prominent Component of the Cartilaginous Primordia in the Developing Human Fetal Spine J. Histochem. Cytochem., October 1, 2003; 51(10): 1331 - 1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Evans, M. V. Fanucchi, G. L. Baker, L. S. Van Winkle, L. M. Pantle, S. J. Nishio, E. S. Schelegle, L. J. Gershwin, L. A. Miller, D. M. Hyde, et al. Atypical development of the tracheal basement membrane zone of infant rhesus monkeys exposed to ozone and allergen Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L931 - L939. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. ten Dam, T. Hafmans, J. H. Veerkamp, and T. H. van Kuppevelt Differential Expression of Heparan Sulfate Domains in Rat Spleen J. Histochem. Cytochem., June 1, 2003; 51(6): 727 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mongiat, J. Fu, R. Oldershaw, R. Greenhalgh, A. M. Gown, and R. V. Iozzo Perlecan Protein Core Interacts with Extracellular Matrix Protein 1 (ECM1), a Glycoprotein Involved in Bone Formation and Angiogenesis J. Biol. Chem., May 2, 2003; 278(19): 17491 - 17499. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Walker, J. M. Whitelock, P. J. Garl, R. A. Nemenoff, K. R. Stenmark, and M. C.M. Weiser-Evans Perlecan Up-Regulation of FRNK Suppresses Smooth Muscle Cell Proliferation via Inhibition of FAK Signaling Mol. Biol. Cell, May 1, 2003; 14(5): 1941 - 1952. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Kinsella, P.-K. Tran, M. C.M. Weiser-Evans, M. Reidy, R. A. Majack, and T. N. Wight Changes in Perlecan Expression During Vascular Injury: Role in the Inhibition of Smooth Muscle Cell Proliferation in the Late Lesion Arterioscler. Thromb. Vasc. Biol., April 1, 2003; 23(4): 608 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Evans, M. V. Fanucchi, L. S. Van Winkle, G. L. Baker, A. E. Murphy, S. J. Nishio, P. L. Sannes, and C. G. Plopper Fibroblast growth factor-2 during postnatal development of the tracheal basement membrane zone Am J Physiol Lung Cell Mol Physiol, December 1, 2002; 283(6): L1263 - L1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Costell, R. Carmona, E. Gustafsson, M. Gonzalez-Iriarte, R. Fassler, and R. Munoz-Chapuli Hyperplastic Conotruncal Endocardial Cushions and Transposition of Great Arteries in Perlecan-Null Mice Circ. Res., July 26, 2002; 91(2): 158 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Henriquez, J. C. Casar, L. Fuentealba, D. J. Carey, and E. Brandan Extracellular matrix histone H1 binds to perlecan, is present in regenerating skeletal muscle and stimulates myoblast proliferation J. Cell Sci., May 15, 2002; 115(10): 2041 - 2051. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Joosten, M. G. A. van Dixhoorn, M. C. Borrias, H. Benediktsson, P. A. van Veelen, C. van Kooten, and L. C. Paul Antibody Response Against Perlecan and Collagen Types IV and VI in Chronic Renal Allograft Rejection in the Rat Am. J. Pathol., April 1, 2002; 160(4): 1301 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mardberg, E. Trybala, F. Tufaro, and T. Bergstrom Herpes simplex virus type 1 glycoprotein C is necessary for efficient infection of chondroitin sulfate-expressing gro2C cells J. Gen. Virol., February 1, 2002; 83(2): 291 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. N. El-Assal, A. Yamanoi, T. Ono, H. Kohno, and N. Nagasue The Clinicopathological Significance of Heparanase and Basic Fibroblast Growth Factor Expressions in Hepatocellular Carcinoma Clin. Cancer Res., May 1, 2001; 7(5): 1299 - 1305. [Abstract] [Full Text] |
||||
![]() |
R. Al Jamal, P. J. Roughley, and M. S. Ludwig Effect of glycosaminoglycan degradation on lung tissue viscoelasticity Am J Physiol Lung Cell Mol Physiol, February 1, 2001; 280(2): L306 - L315. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. McArthur, H. F. Irving-Rodgers, S. Byers, and R. J. Rodgers Identification and Immunolocalization of Decorin, Versican, Perlecan, Nidogen, and Chondroitin Sulfate Proteoglycans in Bovine Small-Antral Ovarian Follicles Biol Reprod, September 1, 2000; 63(3): 913 - 924. [Abstract] [Full Text] |
||||
![]() |
J. Kishibe, S. Yamada, Y. Okada, J. Sato, A. Ito, K. Miyazaki, and K. Sugahara Structural Requirements of Heparan Sulfate for the Binding to the Tumor-derived Adhesion Factor/Angiomodulin That Induces Cord-like Structures to ECV-304 Human Carcinoma Cells J. Biol. Chem., May 12, 2000; 275(20): 15321 - 15329. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mongiat, K. Taylor, J. Otto, S. Aho, J. Uitto, J. M. Whitelock, and R. V. Iozzo The Protein Core of the Proteoglycan Perlecan Binds Specifically to Fibroblast Growth Factor-7 J. Biol. Chem., March 15, 2000; 275(10): 7095 - 7100. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. A. Groffen, J. H. Veerkamp, L. A. H. Monnens, and L. P. W. J. van den Heuvel Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane Nephrol. Dial. Transplant., September 1, 1999; 14(9): 2119 - 2129. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Peng, H. Xie, S. G. Rossi, and R. L. Rotundo Acetylcholinesterase Clustering at the Neuromuscular Junction Involves Perlecan and Dystroglycan J. Cell Biol., May 17, 1999; 145(4): 911 - 921. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Belknap, M. C. M. Weiser-Evans, S. S. Grieshaber, R. A. Majack, and K. R. Stenmark Relationship between Perlecan and Tropoelastin Gene Expression and Cell Replication in the Developing Rat Pulmonary Vasculature Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 24 - 34. [Abstract] [Full Text] |
||||
![]() |
B. Sharma and R. V. Iozzo Transcriptional Silencing of Perlecan Gene Expression by Interferon-gamma J. Biol. Chem., February 20, 1998; 273(8): 4642 - 4646. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Groffen, M. A. Ruegg, H. Dijkman, T. J. van de Velden, C. A. Buskens, J. van den Born, K. J. Assmann, L. A. Monnens, J. H. Veerkamp, and L. P. van den Heuvel Agrin Is a Major Heparan Sulfate Proteoglycan in the Human Glomerular Basement Membrane J. Histochem. Cytochem., January 1, 1998; 46(1): 19 - 28. [Abstract] [Full Text] |
||||
![]() |
R. V. Iozzo, J. Pillarisetti, B. Sharma, A. D. Murdoch, K. G. Danielson, J. Uitto, and A. Mauviel Structural and Functional Characterization of the Human Perlecan Gene Promoter. TRANSCRIPTIONAL ACTIVATION BY TRANSFORMING GROWTH FACTOR-beta VIA A NUCLEAR FACTOR 1-BINDING ELEMENT J. Biol. Chem., February 21, 1997; 272(8): 5219 - 5228. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Whitelock, A. D. Murdoch, R. V. Iozzo, and P. A. Underwood The Degradation of Human Endothelial Cell-derived Perlecan and Release of Bound Basic Fibroblast Growth Factor by Stromelysin, Collagenase, Plasmin, and Heparanases J. Biol. Chem., April 26, 1996; 271(17): 10079 - 10086. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Couchman, R. Kapoor, M. Sthanam, and R.-R. Wu Perlecan and Basement Membrane-Chondroitin Sulfate Proteoglycan (Bamacan) Are Two Basement Membrane Chondroitin/Dermatan Sulfate Proteoglycans in the Engelbreth-Holm-Swarm Tumor Matrix J. Biol. Chem., April 19, 1996; 271(16): 9595 - 9602. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Joseph, M. Ford, C Barth, S Portbury, P. Bartlett, V Nurcombe, and U Greferath A proteoglycan that activates fibroblast growth factors during early neuronal development is a perlecan variant Development, January 11, 1996; 122(11): 3443 - 3452. [Abstract] [PDF] |
||||
![]() |
M. Santra, I. Eichstetter, and R. V. Iozzo An Anti-oncogenic Role for Decorin. DOWN-REGULATION OF ErbB2 LEADS TO GROWTH SUPPRESSION AND CYTODIFFERENTIATION OF MAMMARY CARCINOMA CELLS J. Biol. Chem., November 3, 2000; 275(45): 35153 - 35161. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mongiat, J. Otto, R. Oldershaw, F. Ferrer, J. D. Sato, and R. V. Iozzo Fibroblast Growth Factor-binding Protein Is a Novel Partner for Perlecan Protein Core J. Biol. Chem., March 23, 2001; 276(13): 10263 - 10271. [Abstract] [Full Text] [PDF] |
||||
| Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact |